The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.
Open accessAbstract
BACKGROUND: Measures of low-density lipoprotein (LDL) subfractions have been proposed as an independent risk factor for cardiovascular disease. PURPOSE: To review published studies that reported relationships between LDL subfractions and cardiovascular outcomes. DATA SOURCES: MEDLINE (1950 to 5 January 2009), CAB Abstracts (1973 to 30 June 2008), and Cochrane Central Register of Controlled Trials (2nd quarter of 2008), limited to English-language studies. STUDY SELECTION: 3 reviewers selected longitudinal studies with 10 or more participants that reported an association between LDL subfractions and incidence or severity of cardiovascular disease and in which plasma samples were collected before outcome determination. DATA EXTRACTION: Data were extracted from 24 studies. The 10 studies that used analytical methods available for clinical use (all of which used nuclear magnetic resonance) had full data extraction, including quality assessment (good, fair, or poor). All studies were extracted by 1 researcher and verified by another. DATA SYNTHESIS: All 24 studies, and the subset of 10 nuclear magnetic resonance studies, were heterogeneous in terms of the specific tests analyzed, analytical methods used, participants investigated, and outcomes measured. Higher LDL particle number was consistently associated with increased risk for cardiovascular disease, independent of other lipid measurements. Other LDL subfractions were generally not associated with cardiovascular disease after adjustment for cholesterol concentrations. No study evaluated the incremental value of LDL subfractions beyond traditional cardiovascular risk factors or their test performance. LIMITATION: Publication bias was a possibility. CONCLUSION: Higher LDL particle number has been associated with cardiovascular disease incidence, but studies have not determined whether any measures of LDL subfractions add incremental benefit to traditional risk factor assessment. Routine use of clinically available LDL subfraction tests to estimate cardiovascular disease risk is premature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neither LDL size nor the concentration of small, dense LDL particles adds to CVD prediction in multiple variable analysis beyond the standard lipid risk factors, although small LDL particles predict cardiovascular risk in univariate analysis (35)(36)(37).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [37]
Experimental — accuracy not yet measuredIn the citing paper
“Experimental studies suggest that hypertriglyceridemic HDL may be dysfunctional, 55,56 that small, dense LDL particles may be more susceptible to oxidative modification, 57,58 and that an increased number of atherogenic particles may adversely influence CVD risk 59 ; however, no clinical outcome trials to date have determined whether normalization of particle composition or reduction of particle”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P. N., Larson, M. G., Tofler, G. H., Levy, D. A., Newton‐Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,337
Stampfer, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03540110036029 · Cited by 1,081
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 1×
“…case–control 68 70 100 17 63 (ever smoked) LDL-c: 142 mg/dL Mykkänen et al, 1999 (27) GE Nested case–control 69 100 50 33 20 (current) TC–HDL-c ratio: 6.09 Gardner et al, 1996 (26) GE Nested case–control 59 33 73 No data 42 (not defined) Non–HDL-c: 176 mg/dL CAD coronary artery disease; CHD…”
InfluentialLipoprotein Management in Patients With Cardiometabolic Risk
Brunzell, J. D., Davidson, M. H., Furberg, C. D., Goldberg, R. B., Howard, B. V., Stein, J. H., & Witztum, J. L. (2008) · Diabetes Care · doi:10.2337/dc08-9018 · Cited by 716
Chan, A.-W., & Altman, D. G. (2005) · BMJ · doi:10.1136/bmj.38356.424606.8f · Cited by 613 · cited 1×
“It is likely that the positive secondary analyses were more often reported because negative results may be considered uninteresting and are thus less likely to be selected for journal publication or included in articles because of space limitations (38).”
BackgroundOtvos, J. D., Collins, D. E., Freedman, D. S., SHALAUROVA, I. Y., Schaefer, E. J., McNamara, J. R., Bloomfield, H. E., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.565135 · Cited by 542
Research works printed but not linked: 3
- Chapman MJ, 1998, Eur Heart J, 19, A24
- Zhao XQ, 2003, Med Sci Monit, 9, CR48
- Lamarche B, 2001, Can J Cardiol, 17, 859
Cited by
Sorted by citations
Items 101–163 of 163
Fernández‐Cidón, B., Candás‐Estébanez, B., Gil, M., Amigó, N., Corbella, E., Rodríguez-Sánchez, M. A., Padró‐Miquel, A., Brotons, C., Hernández‐Mijares, A., Calmarza, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071379 · Cited by 11
Ahmad, A. F., Caparros-Martin, J. A., Gray, N., Lodge, S., Wist, J., Lee, S., O’Gara, F., Dwivedi, G., & Ward, N. C. (2023) · Physiological Genomics · doi:10.1152/physiolgenomics.00072.2023 · Cited by 11
Maki, K. C., Dicklin, M. R., Davidson, Mize, P. D., & Kulkarni, K. R. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s27963 · Cited by 11
Sala‐Vila, A., Cofán, M., Mateo‐Gállego, R., Cenarro, A., Civeira, F., & Ros, E. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.01.011 · Cited by 11
Más allá de los parámetros lipídicos tradicionales en la enfermedad renal crónica
Bermúdez-López, M., Betriu, À., Valdivielso, J. M., del Pino, T. B., Arroyo, D., & Fernández, E. (2017) · Nefrología · doi:10.1016/j.nefro.2017.09.008 · Cited by 9
Kenkre, J. S., Mazaheri, T., Neely, R. D. G., Soran, H., Datta, D. B. N., Penson, P. E., Downie, P., Yates, A. M., Hayden, K., Patel, M., et al. (2025) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632251315303 · Cited by 8
Kuthethur, S., Prabhu, A., Hegde, A., Marathe, A., & Kumar, K. B. (2015) · International Journal of Biomedical Research · doi:10.7439/ijbr.v6i3.1730 · Cited by 8
Donato, L. J., & Meeusen, J. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815499-1.00028-4 · Cited by 8
do Vale, M. R. L., Buckner, L., Mitrofan, C. G., Tramontt, C. R., Kargbo, S. K., Khalid, A., Ashraf, S., Mouti, S., Dai, X., Unwin, D., et al. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000378 · Cited by 7
Replacement of Sedentary Time with Physical Activity
Phillips, C. M., Dillon, C. B., & Perry, I. J. (2017) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001511 · Cited by 7
Smith, S. C., Taylor, A. J., Weintraub, W. S., Kushner, F. G., Lauer, M. S., Benjamin, J. M., Budoff, M. J., Fayad, Z. A., Foster, E., Greenland, P., et al. (2011) · Cited by 7
Beyond the traditional lipid parameters in chronic kidney disease
Bermúdez-López, M., Betriu, À., Valdivielso, J. M., del Pino, T. B., Arroyo, D., & Fernández, E. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.11.016 · Cited by 7
Stanciulescu, L. A., Scafa‐Udriște, A., Duduianu, C., Stan, R., Nicolescu, A. F., Deleanu, C., & Dorobanţu, M. (2022) · Diagnostics · doi:10.3390/diagnostics12071675 · Cited by 6
Suh, S., Park, H., Jin, S., Kim, H. J., Bae, J. C., Park, S. Y., Park, M. K., Kim, D. K., Cho, N. H., & Lee, M. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12091 · Cited by 6
Triglycerides and Cardiovascular Disease : A Scientific Statement From the
Pennathur, S., Kris‐Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Stone, N. J., Ballantyne, C. M., et al. (2011) · Cited by 6
Diallo, A. F., Abbas, M., Goodney, G. A., Price, E. T., & Gaye, A. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00332.2024 · Cited by 5
López‐López, D., Carral, J. M. C., Araujo, R. V., Losa‐Iglesias, M. E., Vallejo, R., Rodríguez‐Sanz, D., & Calvo‐Lobo, C. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.2.149 · Cited by 5
Bakillah, A., Khamees, K. O., AlSubaiee, M., Soliman, A. F., Arab, M. A., Bashir, S. F., Hussaini, A. A., Otaibi, A. A., Mubarak, S. A. S., Iqbal, J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020487 · Cited by 4
Montero, D., Dutheil, F., Walther, G., Pérez‐Martin, A., Soto-Esclapez, L., Vinet, A., & Roche, E. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.01.025 · Cited by 4
Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation
Masip, J., Jorba, R., López-Dupla, M., Domingo, P., Pacheco, Y. M., García‐Pardo, G., Martínez, E., Viladés, C., Veloso, S., Alba, V., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158071 · Cited by 4
Kanda, E., Ai, M., Iwamoto, A., Okazaki, M., Maeda, Y., Sasaki, S., & Yoshida, M. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-234 · Cited by 4
Utility of Advanced Lipoprotein Testing in Clinical Practice
Feingold, K. R., & Grünfeld, C. (2016) · Europe PMC (PubMed Central) · Cited by 4
Zambon, A., Gentile, L., Galimberti, F., Manzato, E., Giaccari, A., Sesti, G., Belfiore, A., Norata, G. D., Temporelli, P. L., Frulloni, L., et al. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104214 · Cited by 3
Taylor, J., Weintraub, W. S., WENGER, N. K., Kushner, F. G., Lauer, M. S., Shaw, L. J., Smith, S. C., Fayad, Z. A., Foster, E., Hlatky, M. A., et al. (2011) · Cited by 3
Hande, L. N., Kjellmo, C. A., Pettersen, K., Ljunggren, S., Karlsson, H., Cederbrant, K., Marcusson‐Ståhl, M., Hovland, A., & Lappegård, K. T. (2022) · Biomedicines · doi:10.3390/biomedicines10081809 · Cited by 3
Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant Diabetes
Cobble, M. E., Mize, P. D., & Brinton, E. A. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_2 · Cited by 3
Shao, P., Ou, J., Wu, R., Fang, M., Chen, H., Xu, Y., & Zhao, J. (2013) · PubMed · doi:10.3969/j.issn.1672-7347.2013.04.005 · Cited by 3
Optimal Non-invasive Strategies to Reduce Recurrent Atherosclerotic Cardiovascular Disease Risk
Jones‐O’Connor, M., & Natarajan, P. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0741-4 · Cited by 3
Exploring the dairy milk matrix beyond isolated nutrients—a narrative review
O’Sullivan, T. A., & Nicholl, A. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2648097 · Cited by 2
Garvey, W. T., Arathuzik, G., Miller, G. D., & Ard, J. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-24687-1_23 · Cited by 2
Quesada, J. A., Bertomeu‐González, V., Orozco‐Beltrán, D., Cordero, A., Gil-Guillén, V. F., López‐Pineda, A., Nouni-García, R., & Carratalá‐Munuera, C. (2023) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2023.07.006 · Cited by 2
2009 World Congress on the Insulin Resistance Syndrome: Cardiovascular Disease Concepts
Bloomgarden, Z. T. (2010) · Diabetes Care · doi:10.2337/dc10-zb07 · Cited by 2
Small dense low-density lipoprotein particles: priority as a treatment target in Type 2 diabetes?
Gerber, P. A., Spinas, G. A., & Berneis, K. K. (2011) · Diabetes Management · doi:10.2217/dmt.11.73 · Cited by 2
Kjellmo, C. A., Pop, G., Lappegård, K. T., & Hovland, A. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319845966 · Cited by 2
Li, T., Zhang, Y., Xu, J., Wang, L., Zhang, F., & Cong, H. (2022) · Angiology · doi:10.1177/00033197221112134 · Cited by 2
Liu, Y., Wang, X., Han, J., Liu, L., Jin, Y., Jin, L., & Ye, P. (2019) · Medicine · doi:10.1097/md.0000000000015062 · Cited by 2
Physical Inactivity and Clinical Cardiovascular Impact -Updating Narrative Review
(2019) · Worldwide Medicine · doi:10.5455/ww.302644346 · Cited by 2
Integrating Advanced Lipid Testing and Biomarkers in Assessment and Treatment
Sykes, A. V., Patel, N., Lee, D. H., & Taub, P. R. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01775-5 · Cited by 2
Kang, D., Yang, H., Park, K. W., Lee, S., Lee, M., Lee, D.-W., Lee, H., Kang, H., Koo, B., Chae, I., et al. (2012) · Korean Circulation Journal · doi:10.4070/kcj.2012.42.8.551 · Cited by 1
Taylor, A. J., Weintraub, W. S., WENGER, N. K., Kushner, F. G., Lauer, M. S., & Shaw, L. J. (2010) · Cited by 1
Terapia nutricional en el paciente obeso con insulinorresistencia y riesgo cardiovascular
Nubiola, A., Remolins, I., & Nubiola, M. (2015) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2015.11.002 · Cited by 1
Alternate Day Fasting: Effects on Body Weight and Chronic Disease Risk in Humans and Animals
Varady, K. A. (2012) · Springer eBooks · doi:10.1007/978-3-642-29056-5_23 · Cited by 1
Jacobs, A. K., Smith, S. C., Taylor, A. J., Weintraub, W. S., Kushner, F. G., Lauer, M. S., Benjamin, J. M., Budoff, M. J., Fayad, Z. A., Foster, E., et al. (2011) · Cited by 1
DIET-INDUCED HYPERLIPIDEMIA AND ATHEROSCLEROSIS IN WHITE RABBITS.
As, A., Ti, A., & Fatoki, J. O. (2013) · Cited by 1
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., Johnson, M. R., et al. (2013) · Cited by 1
von Bibra, H. (2014) · CardioVasc · doi:10.1007/s15027-014-0376-z · Cited by 1
Small Dense Low-density Lipoprotein and Cardiovascular Disease
Suh, S., & Lee, M. (2012) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2012.1.1.1
Padhi, E. M. T. (2015) · The Atrium (University of Guelph)
2. Cholesterol and cognitive functioning in persons free from stroke and dementia
Crichton, G. E., Sullivan, K., & Elias, M. F. (2016) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-821-6_2
Ratio of Atherogenic and Antiatherogenic Lipoproteins in RVO
Shaikh, D. S. R. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i6.94
Côté, J. A. (2013) · Corpus Université Laval (Université Laval)
Lipoprotein Subfractions in Clinical Practice
Meeusen, J. W. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_27
Fonseca, M. I. H. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2021.tde-29122021-150846
Nowicki, J., & Murray, M. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00149-7
Murray, M. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00148-6
Aldin, M. N., Fisberg Regina, M., Rogero, M. M., Sarti, F. M., & Damasceno Nágila, R. T. (2024) · Journal of Advanced Pediatrics and Child Health · doi:10.29328/journal.japch.1001068
Chary, A., Tohidi, M., & Hedayati, M. (2023) · Figshare · doi:10.6084/m9.figshare.24483547
Li, T., Wang, L., Li, W., Wang, L., Yang, H., & Cong, H. (2026) · Angiology · doi:10.1177/00033197251415207
Şahin, F., Saral, N. Y., Toker, A., Tay, İ., Tekin, N., Serteser, M., & Baykal, A. T. (2026) · Scientific Reports · doi:10.1038/s41598-026-42349-7
Current and emerging nutrition interventions in cardiac rehabilitation: a narrative review
Small, S. L., Iglesies‐Grau, J., Gariepy, C., Williams, J., Rishis, E., Terada, T., & Kirkham, A. (2026) · Translational Exercise Biomedicine · doi:10.1515/teb-2026-0002
Şahin, F., Tekin, N., Toker, A., Saral, N. Y., İrem, T. A. Y., Serteser, M., & Baykal, A. T. (2026) · Research Square · doi:10.21203/rs.3.rs-9622101/v1
Metadata
- Authors
- Ip, S., Lichtenstein, A. H., Chung, M., Lau, J., & Balk, E. M.
- Affiliations
- Tufts University (US)
- Corresponding author
- Ip, Stanley
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2009-04-07
- Volume
- 150
- Issue
- 7
- Pages
- 474-484
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- PMC
- PMC6880859
- OpenAlex
- W2048908649
- Cited by
- 163
- References
- 44
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 4 · 2019: 9 · 2018: 10 · 2017: 10 · 2016: 7 · 2015: 9 · 2014: 8 · 2013: 14 · 2012: 15
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (290-020022)
- National Heart, Lung, and Blood Institute (R01HL054727, R01HL074388)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- low-density lipoprotein subfractions, LDL particle number, cardiovascular risk, cardiovascular outcomes, cardiovascular risk assessment, LDL cholesterol, lipoprotein particle size
- MeSH terms
- Cardiovascular Diseases, Humans, Lipoproteins, LDL, Risk Factors, Incidence, Disease Progression, Nuclear Magnetic Resonance, Biomolecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
